Immediately after three days of TME Stimulation, 41 ± 17.4% and 18.7 ± 6.3% of tumor cells were characterized by the CD44+/β1+ and CD44+/CD24low/− phenotypes, respectively (Table 1A). Here, CD44 is linked to neoplasm.